Genetic differences may influence joint pain among women taking lifesaving breast cancer drugs
Tuesday, June 1, 2010 - 14:41
in Health & Medicine
Aromatase inhibitor-associated arthralgia is a major side effect in breast cancer survivors, producing joint pain so severe that as many as ten percent of women discontinue their therapy prematurely while undergoing treatment with these lifesaving drugs. New research reveals a possible genetic basis for why these side effects occur.